Searched for
KOTAK SECURITIES SUN PHARMA
Affordable housing finance firms likely to regain growth in FY27, but macro risks loom: KotakAffordable housing finance companies are poised for a growth rebound from FY27, according to Kotak Institutional Securities. After a subdue...- Capricorn ♑ July 2026 Horoscope, Monthly Predictions: Delays Could Lead to Bigger Rewards Than Expected♑ Capricorn Monthly Horoscope (1st July 2026 to 31st July 2026): The Capricorn Monthly Horoscope indicates a month focused on work and pers...
- Sagittarius ♐ July 2026 Horoscope, Monthly Predictions: A Major Turning Point Could Change Your Relationships♐ Sagittarius Monthly Horoscope (1st July 2026 to 31st July 2026): Your Sagittarius Monthly Horoscope indicates a month where relationships...
- Leo ♌ July 2026 Horoscope, Monthly Predictions: Something Big Is Brewing Behind the Scenes, A Major Comeback Is Closer Than You Think♌ Leo Monthly Horoscope (1st July 2026 to 31st July 2026): The Leo Monthly Horoscope indicates a month of inner reflection. The Sun remains...
- July 2026 Planetary Transits Guide: Dates, Meanings and Zodiac Effects- Energetic, Karmic, EvolutionaryJuly 2026 brings a powerful mix of emotional growth, relationship developments, communication shifts, and karmic lessons as several importa...
- Gemini ♊ July 2026 Horoscope, Monthly Predictions: Relationships Flourish While Career Progress Happens Quietly♊ Gemini Monthly Horoscope (1st July 2026 to 31st July 2026): The Gemini Monthly Horoscope indicates a transformative and eventful month. T...
- Stocks in news: Vedanta, Honasa Consumer, IRCTC, Bajaj Auto, Tata MotorsIndian markets experienced profit booking, falling over a percent amidst a weak global trend. Key stocks like Vedanta, Honasa Consumer, IRC...
- Defence valuations 'obnoxious'; private banks look strong: Sandip Sabharwal's full market playbookInvestor Sandip Sabharwal cautions that while the defence rally is real, many stock prices have outpaced reality. He favors Bharat Electron...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Central Drugs Laboratories find 46 drug samples not of standard quality for MayHealth officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratorie...
- Sensex rises 291 points, Nifty closes above 24,100; Tech Mahindra, Sun Pharma among top gainersIndian stock markets saw a positive start on Monday, with Sensex and Nifty inching up after Friday's dip. Tech Mahindra led the gains, whil...
- Reliance, financials and defence top investment picks as market leadership broadens: Rahul ShahReliance Industries is poised for a turnaround, with strong earnings, a Jio Platforms IPO, and AI/energy investments promising significant ...
- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
- June 21 Cosmic Forecast: How Sun in Cancer and Mars in Taurus Will Impact Every Zodiac SignJune 21, 2026 brings one of the most significant astrological shifts of the month as the Sun enters Cancer and Mars moves into Taurus on th...
- SBI Funds Management gets Sebi nod for IPOSBI Funds Management, India's largest mutual fund house, has secured SEBI's nod for its upcoming Initial Public Offering, expected to launc...
- Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 crGlobal investors including Societe Generale and Prudential Hong Kong, alongside Indian mutual funds and insurance companies, have bought a ...
- Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soonIndian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
Load More
